{"id":2299,"date":"2025-12-24T01:30:16","date_gmt":"2025-12-24T00:30:16","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/?page_id=2299"},"modified":"2026-02-13T15:12:05","modified_gmt":"2026-02-13T14:12:05","slug":"publications","status":"publish","type":"page","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/publications\/","title":{"rendered":"Scientific Publications"},"content":{"rendered":"\n<div class=\"wp-block-group alignwide has-global-padding is-layout-constrained wp-container-core-group-is-layout-4383d167 wp-block-group-is-layout-constrained\"><h1 style=\"padding-top:var(--wp--preset--spacing--40);padding-bottom:var(--wp--preset--spacing--40);\" class=\"wp-block-post-title\">Scientific Publications<\/h1>\n\n<div class=\"post-type-archive-publication\">\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-1&quot;, &quot;openByDefault&quot;: true }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-open is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-1-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-1\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2026 <span class=\"nb-publications\">(3)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-1\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-1-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S095279152600018X?viaihub\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Evolution and prospects for the definition of clinically useful endpoints in Sj\u00f6gren disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Beydon M, Bowman SJ, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Curr Opin Oncol.<\/b> | 2026 Feb;98:102707. doi: 10.1016\/j.coi.2025.102707. Epub 2025 Dec 11. PMID: 41385979 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0003496725046047\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">A genetic variant of BAFF is associated with the risk of lymphoma in Sj\u00f6gren disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Beydon M, Dulin M, Ly B, Verstuyft C, Cardoso A, Juge PA, Dieud\u00e9 P, Lessard CJ, Khatri B, Radziszewski M, Le Guern V, Gottenberg JE, Seror R, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2026 Jan 14. doi: 10.1016\/j.ard.2025.12.010. PMID: 41539891.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0952791525001839\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Salivary gland organoids and the future of modeling autoimmune epithelitis in Sj\u00f6gren&rsquo;s disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Yang T, Goudarzi N, Kroese FGM, Mariette X, Pringle S, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Curr Opin Immunol.<\/b> | 2026 Feb;98:102707. doi: 10.1016\/j.coi.2025.102707. Epub 2025 Dec 11. PMID: 41385979 Review.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-2&quot;, &quot;openByDefault&quot;: true }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-open is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-2-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-2\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2025 <span class=\"nb-publications\">(24)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-2\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-2-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/jitc.bmj.com\/content\/13\/9\/e012756\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Guitton R, Laparra A, Chanson N, Champiat S, Danlos FX, Michot JM, Messayke S, Marabelle A, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Immunother Cancer.<\/b> | 2025 Sep 23;13(9):e012756. doi: 10.1136\/jitc-2025-012756. PMID: 40992784<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanrhe\/article\/PIIS2665-9913(25)00181-X\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Machine learning to classify the focus score and Sj\u00f6gren&rsquo;s disease using digitalised salivary gland biopsies: a retrospective cohort study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Duquesne J, Basseto L, Claye C, Barnes M, Pontarini E, Gallagher-Syed A, Bombardieri M, Fisher BA, Nayar S, Brown R, Tzioufas A, Goules A, Chatzis L, Thompson K, Berry J, Ng WF, Bandeira M, Rom\u00e3o VC, L\u00f3pez-Presa MD, Nocturne G, Ouerdane W, Molina T, Lazure T, Adam C, Mariette X, Bouget V, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2025 Sep 29:S2665-9913(25)00181-X. doi: 10.1016\/S2665-9913(25)00181-X. Online ahead of print. PMID: 41038216<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanrhe\/article\/PIIS2665-9913(25)00258-9\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Can AI be used to classify the focus score in Sj\u00f6gren&rsquo;s disease?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bharaj TK, Skarstein K.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2025 Sep 29:S2665-9913(25)00258-9. doi: 10.1016\/S2665-9913(25)00258-9. Online ahead of print. PMID: 41038217 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/doi.org\/10.1093\/cei\/uxaf050\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Marie Naigeon, Samuel Bitoun, Matthieu Roulleaux Dugage, Caroline de Oliveira, Caroline Berthot, Benjamin Besse, Aur\u00e9lien Marabelle, Fran\u00e7ois-Xavier Danlos, Xavier Mariette, Nathalie Chaput.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxaf050<\/b> | https:\/\/doi.org\/10.1093\/cei\/uxaf050<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/ard.eular.org\/article\/S0003-4967(25)00962-8\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Primary Sj\u00f6gren&rsquo;s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sj\u00f6gren&rsquo;s Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bowman SJ, Seror R, Porcher R, Arends S, de Wolff L, Verstappen G, Devauchelle-Pensec V, Jousse-Joulin S, Baldini C, Bombardieri M, Pontarini E, Hueber W, Marvel J, Goswami P, Cornec D, Fisher BA, Nayar S, Barone F, Ng WF, Gottenberg JE, Bootsma H, D\u00f6rner T, Pincemin M, Bouillot C, Hammitt KM, Wahren-Herlenius M, van Roon J, Nocturne G, Laigle L, Moingeon P, Christodoulou A, Sreih AG, van Maurik A, Chen WH, Wisniacki N, Piatrova A, Jonsson R, Gergely P, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2025 Jul;84(7):1068-1089. doi: 10.1016\/j.ard.2025.05.004. Epub 2025 Jun 17. PMID: 40527714 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-24-1230\/762930\/Gut-microbiota-modulation-through-Akkermansia-spp\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potency.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillere R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Bleriot C, Liu P, Zhao L, Creusot L, Rolhion N, Derosa L, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Cancer Discov.<\/b> | 2025 Jun 11. doi: 10.1158\/2159-8290.CD-24-1230. Online ahead of print. PMID: 40498998<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0003496725009094\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Development of salivary gland organoids derived from patient biopsies: a functional model of Sj\u00f6gren&rsquo;s disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meudec L, Goudarzi N, Silva-Saffar SE, Pascaud J, Jaulin F, Pascal Q, Lazure T, Bechara R, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2025 May 19:S0003-4967(25)00909-4. doi: 10.1016\/j.ard.2025.04.020. Online ahead of print. PMID: 40393919<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03564-1\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Jouret M, Viel S, Fournier B, Benezech S, Avouac J, Scherlinger M, Belot A; C3I consortium.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Res Ther.<\/b> | 2025 May 10;27(1):102. doi: 10.1186\/s13075-025-03564-1. PMID: 40349090 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2665991324003771?dgcid=author\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">CAR T-cell therapy in autoimmune diseases: where are we and where are we going?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Scherlinger M, Nocturne G, Radic M, Launay D, Richez C, Bousso P, Forcade E, Meyer A, Jorgensen C, Bigenwald C, Cornec D, Sibilia J, Choquet S, Martin T, Belot A, Jouret M, Bitoun S, Amoura Z, Hermine O, Mariette X, Donnadieu E, Avouac J; Club for Innovative Immunotherapies in Immune-mediated Inflammatory diseases (C3I).<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2025 Mar 26:S2665-9913(24)00377-1. doi: 10.1016\/S2665-9913(24)00377-1. PMID: 40157379 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39928358\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ahmed S, Pfeiffer RM, Jackson SS, Song M, Mariette X, Seror R, Engels EA.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford)<\/b> | 2025 Feb 10:keaf092. doi: 10.1093\/rheumatology\/keaf092. Online ahead of print. PMID: 39928358<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40165410\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Hueso T, Cagnat J, Ouali K, Haberstich M, Henry B, Danu A, Bigenwald C, Merad M, Messayke S, Laparra A, Sakkal M, Smolenschi C, Hollebecque A, Gazzah A, Baldini C, Bahleda R, Besse B, Rigaud C, Minard-Colin V, Ribrag V, Laghouati S, Chachaty E, Barlesi F, Marabelle A,\u00a0Lambotte O, Massard C, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Infect Dis.<\/b> | 2025 Dec 24;81(5):1019-1022. doi: 10.1093\/cid\/ciaf164.PMID:\u00a040165410<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39755430\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Breaking the link: IL-6 targeting to uncouple toxicity and efficacy in patients treated with immune checkpoint blockade.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Roulleaux Dugage M,\u00a0Lambotte O, Mariette X, Marabelle A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol.<\/b> | 2025 Jan ;36(1):6-9. doi: 10.1016\/j.annonc.2024.09.007. Epub 2024 Nov 26.PMID:\u00a039755430<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39714261\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chanson N, Galvagni A, Ramos-Casals M, Ruiz JI, Suijkerbuijk KPM, Gente K, Kerschen P, Karam JD, Belkhir R, Outh R, Closs-Prophette F, Garcia Morillo JS, Robles-Marhuenda \u00c1, Michot JM, Voisin AL, Messayke S, Laparra A, Robert C, Suarez-Almazor M, Mariette X, Lambotte O; ICIR.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford).<\/b> | 2025 Jun 1;64(6):3685-3690. doi: 10.1093\/rheumatology\/keae711. PMID: 39714261<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39869015\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Long-term immune related adverse events.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pla\u00e7ais L, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Curr Opin Oncol.<\/b> | 2025 Mar 1;37(2):142-149. doi: 10.1097\/CCO.0000000000001113. Epub 2024 Dec 16.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/rmdopen.bmj.com\/content\/11\/1\/e005062\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Evaluation of RA-associated interstitial lung disease in patients treated with JAK inhibitors (MAJIK-SFR cohort).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Triboulet F, Juge PA, Truchetet ME, Pham T, Roux N, Flipo RM, Lesk\u00e9 C, Roux CH, Seror R, Basch A, Brocq O, Chazerain P, Coury-Lucas F, Damade R, Dernis E, Gottenberg JE, Ramon A, Ruyssen-Witrand A, Salmon JH, Shipley \u00c9, Tournadre A, Prati C, Dieud\u00e9 P, Avouac J.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2025 Jan 6;11(1):e005062. doi: 10.1136\/rmdopen-2024-005062. PMID: 39762124.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanrhe\/article\/PIIS2665-9913(24)00377-1\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">CAR T\u2011cell therapy in autoimmune diseases: where are we and where are we going?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Scherlinger M, Nocturne G, Radic M, Launay D, Richez C, Bousso P, Forcade E, Meyer A, Jorgensen C, Bigenwald C, Cornec D, Sibilia J, Choquet S, Martin T, Belot A, Jouret M, Bitoun S, Amoura Z, Hermine O, Mariette X, Donnadieu E, Avouac J; C3I.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2025 Jun;7(6):e434-e447. doi: 10.1016\/S2665-9913(24)00377-1. PMID: 40157379.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003496725005044\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Primary Sj\u00f6gren\u2019s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bowman SJ, Seror R, Porcher R, Arends S, de Wolff L, Verstappen G, Devauchelle-Pensec V, Jousse-Joulin S, Baldini C, Bombardieri M, Pontarini E, Hueber W, Marvel J, Goswami P, Cornec D, Fisher BA, Nayar S, Barone F, Ng WF, Gottenberg JE, Bootsma H, D\u00f6rner T, Pincemin M, Bouillot C, Hammitt KM, Wahren-Herlenius M, van Roon J, Nocturne G, Laigle L, Moingeon P, Christodoulou A, Sreih AG, van Maurik A, Chen WH, Wisniacki N, Piatrova A, Jonsson R, Gergely P, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2025 Jul;84(7):1068-1089. doi: 10.1016\/j.ard.2025.05.004. PMID: 40527714.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.43096\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Distinct Pathophysiologic Pathways Support Stratification of Sj\u00f6gren&rsquo;s Disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nguyen Y, Beydon M, Gottenberg JE, Morel J, Perdriger A, Dernis E, Cornec D, Devauchelle-Pensec V, S\u00e8ne D, Dieud\u00e9 P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Mariette X, Seror R, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Rheumatol.<\/b> | 2025 Jul;77(7):876-883. doi: 10.1002\/art.43096. PMID: 39721742.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/academic.oup.com\/rheumatology\/article\/64\/7\/4172\/7667707\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Cancer risk of JAK inhibitors and biologics among older Americans with rheumatoid arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ahmed S, Pfeiffer RM, Jackson SS, Song M, Mariette X, Seror R, Engels EA.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford).<\/b> | 2025 Jul 1;64(7):4172-4180. doi: 10.1093\/rheumatology\/keaf092. PMID: 39928358.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003496725045492\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Transcriptomic stratification predicts response to rituximab, abatacept, or HCQ+leflunomide in 3 RCTs of Sj\u00f6gren\u2019s disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chevet B, Devauchelle-Pensec V, Pontarini E, Baloche V, Bombardieri M, Bowman SJ, Barnes M, Sreih AG, Liu J, Kelly S, Christodoulou A, Moingeon P, Laigle L, Soret P, Le Dantec C, Pers JO, Alarcon-Riquelme ME, Barturen G, Mariette X, van Roon J, Seror R, Nocturne G, Cornec D, Foulquier N; PRECISEADS &amp; NECESSITY consortia.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2025 Dec 24. doi: 10.1016\/j.ard.2025.11.017. PMID: 41448992.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1297319X25003216\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">French recommendations for assessing and managing the risk of cancer before initiating targeted therapies for chronic rheumatic inflammatory diseases.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Avouac J, Fogel O, Beydon M, Fr\u00e9mont GM, Birsen G, Carcopino X, Immediato Daien C, Desouches S, Domblides C, Gaujoux-Viala C, Gottenberg JE, Letarouilly JG, Nocturne G, Prati C, Salmon JH, Sellam J, Truchetet ME, Wislez M, Pico-Philippe I, Vacher D, Seror R, Molto A; French Society of Rheumatology.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine.<\/b> | 2025 Oct;92(5):105944. doi: 10.1016\/j.jbspin.2025.105944. PMID: 40659179.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.nature.com\/articles\/s41375-025-02699-z\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Molecular profiling and risk stratification in solitary bone plasmacytoma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Burroni B, Harel S, Seror R, Ascione S, Kirova Y, Damotte D, Belkhir R, Lazure T, Meignin V, Decroocq J, Audard V, Birsen R, Willems L, Larousserie F, Franchi P, Velut Y, Chapuis N, Derrier L, Manier S, Deau-Fischer B, Henry J, Pavageau L, Talbot A, Royer B, Bouscary D, Arnulf B, Corre J, Vignon M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Leukemia.<\/b> | 2025 Oct;39(10):2568.-2572. doi: 10.1038\/s41375-025-02699-z. PMID: 40954216<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/jitc.bmj.com\/content\/13\/9\/e012756\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Guitton R, Laparra A, Chanson N, Champiat S, Danlos FX, Michot JM, Messayke S, Marabelle A, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Immunother Cancer.<\/b> | 2025 Sep 23;13(9):e012756. doi: 10.1136\/jitc-2025-012756. PMID: 40992784.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.adu9790\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">CAR T cell\u2013mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ben Khelil M, Arbab A, Srikanthan J, Marcos-Kovandzic L, Verg\u00e9 V, Pag\u00e8s A, Rengassamy J, Amine-Hneineh R, Aglave M, Jelin R, Ribrag V, Rahali W, Goutebroze PA, de Botton S, Menger L, Antony-Debr\u00e9 I, Micol JB, Marzac C, Castilla Llorente C, Bigenwald C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Sci Transl Med.<\/b> | 2025 Sep 24;17(817):eadu9790. doi: 10.1126\/scitranslmed.adu9790. PMID: 40991725.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-3&quot;, &quot;openByDefault&quot;: true }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-open is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-3-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-3\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2024 <span class=\"nb-publications\">(30)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-3\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-3-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39179255\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Assoumou L, Bald\u00e9 R, Katlama C, Abbar B, Delobel P, Allegre T, Lavole A, Makinson A, Zaegel-Faucher O, Greillier L, Soulie C, Veyri M, Bertheau M, Algarte Genin M, Gibowski S, Marcelin AG, Bihan K, Baron M, Costagliola D, Lambotte O, Spano JP.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Immunother Cancer.<\/b> | 2024 Aug 22;12(8):e009728. doi: 10.1136\/jitc-2024-009728. PMID: 39179255.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39096929\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sj\u00f6gren&rsquo;s disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet.<\/b> | 2024 Aug 10;404(10452):540-553. doi: 10.1016\/S0140-6736(24)01211-X. Epub 2024 Jul 31. PMID: 39096929 Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39182508\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sj\u00f6gren&rsquo;s disease activity: a multicentre, retrospective, observational study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Rocca J, Beydon M, Le Guern V, Hachulla E, Couderc M, Jousse-Joulin S, Devauchelle-Pensec V, Gottenberg JE, Vittecoq O, Lavigne C, Schmidt J, Larroche C, Mariette X, Seror R, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2024 Aug 22:S2665-9913(24)00198-X. doi: 10.1016\/S2665-9913(24)00198-X. Online ahead of print. PMID: 39182508<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38642007\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pla\u00e7ais M, Laparra A, Maria ATJ, Kramkimel N, Perret A, Manson G, Comont T, Coutte L, Nardin C, Ouali K, Danlos FX, No\u00ebl N, Messayke S, Michel M, Lambotte O, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Am J Hematol.<\/b> | 2024 Jul;99(7):1427-1430. doi: 10.1002\/ajh.27339. Epub 2024 Apr 20. PMID: 38642007No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38733717\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">G\u00e9raud A, Hueso T, Laparra A, Bige N, Ouali K, Cauquil C, Stoclin A, Danlos FX, Hollebecque A, Ribrag V, Gazzah A, Goldschmidt V, Baldini C, Suzzoni S, Bahleda R, Besse B, Barlesi F, Lambotte O, Massard C, Marabelle A, Castilla-Llorente C, Champiat S, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2024 Jul;205:114075. doi: 10.1016\/j.ejca.2024.114075. Epub 2024 May 4. PMID:38733717Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38729086\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Cancer Treat Rev.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rached L, Laparra A, Sakkal M, Danlos FX, Barlesi F, Carbonnel F, De Martin E, Ducreux M, Even C, Le Pavec J, Michot JM, M Ribeiro J, Scotte F, Ponce Aix S, Lambotte O, Baldini C, Champiat S.<\/b> | 2024 Jun;127:102751. doi: 10.1016\/j.ctrv.2024.102751. Epub 2024 May 4. PMID: 38729086 Free article. Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38760922\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Editorial: Another brick in the CDST wall.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Amiot A, Antoine M, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2024 May 17. doi: 10.1111\/apt.18023. Online ahead of print. PMID: 38760922 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38670725\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Singh N, Shahane A, Sparks JA, Bitoun S, Cappelli LC.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheum Dis Clin North Am.<\/b> | 2024 May;50(2):269-279. doi: 10.1016\/j.rdc.2024.02.002. Epub 2024 Mar 8. PMID: 38670725Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38670727\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune Checkpoint Inhibitor-induced Sicca Syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bitoun S, Rousseau A, Gosset M, Belkhir R, Lazure T, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheum Dis Clin North Am.<\/b> | 2024 May;50(2):291-300. doi: 10.1016\/j.rdc.2024.02.004. PMID: 38670727Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38643707\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Cariou PL, Pobel C, Michot JM, Danlos FX, Besse B, Carbonnel F, Mariette X, Marabelle A, Messayke S, Robert C, Routier E, No\u00ebl N, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2024 Apr 14;204:114065. doi: 10.1016\/j.ejca.2024.114065. Online ahead of print. PMID: 38643707<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38641350\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Luke JJ, Davar D, Andtbacka RH, Bhardwaj N, Brody JD, Chesney J, Coffin R, de Baere T, de Gruijl TD, Fury M, Goldmacher G, Harrington KJ, Kaufman H, Kelly CM, Khilnani AD, Liu K, Loi S, Long GV, Melero I, Middleton M, Neyns B, Pinato DJ, Sheth RA, Solomon SB, Szapary P, Marabelle A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Immunother Cancer.<\/b> | 2024 Apr 18;12(4):e008378. doi: 10.1136\/jitc-2023-008378. PMID: 38641350Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38630478\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Gougis P, Hamy AS, Jochum F, Bihan K, Carbonnel M, Salem JE, Dumas E, Kabirian R, Grandal B, Barraud S, Coussy F, Hotton J, Savarino R, Marabelle A, Cadranel J, Spano JP, Laas E, Reyal F, Abbar B.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JAMA Netw Open.<\/b> | 2024 Apr 1;7(4):e245625. doi: 10.1001\/jamanetworkopen.2024.5625. PMID: 38630478Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38642007\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Drug-induced autoimmune hemolyticanemias related to immune checkpoint inhibitors, therapeutic management, and outcome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pla\u00e7ais M, Laparra A, Maria ATJ, Kramkimel N, Perret A, Manson G, Comont T, Coutte L, Nardin C, Ouali K, Danlos FX, No\u00ebl N, Messayke S, Michel M, Lambotte O, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Am J Hematol.<\/b> | 2024 Apr 20. doi: 10.1002\/ajh.27339. Online ahead of print. PMID: 38642007<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38430989\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Jeay M, Carbonnel F, Robert C, Mussini C, Bellanger C, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Res Hepatol Gastroenterol.<\/b> | 2024 Apr;48(4):102311. doi: 10.1016\/j.clinre.2024.102311. Epub 2024 Feb 29.PMID: 38430989 Free article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38644976\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kachaner A, Seror R, Aubart FC, Henry J, Lazure T, Emile JF, Mariette X, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JBMR Plus.<\/b> | 2024 Apr 20;8(5):ziae043. doi: 10.1093\/jbmrpl\/ziae043. eCollection 2024 May. PMID: 38644976Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38608698\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Blanchard F, Henry B, Vijayaratnam S, Canou\u00ef E, Moura A, Thouvenot P, Bracq-Dieye H, Tessaud-Rita N, Val\u00e8s G, Diakit\u00e9 A, Leclercq A, Lecuit M, Charlier C; Listeria monocytogenes-associated Spontaneous Peritonitis Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Infect Dis.<\/b> | 2024 Apr 9:S1473-3099(24)00151-8. doi: 10.1016\/S1473-3099(24)00151-8. Online ahead of print.PMID: 38608698<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38548063\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Reporting and analysis of immunotherapy trials adverse events: what is going wrong, how to do better?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pourmir I, Nebbache R, Champiat S, Lambotte O; Cancer Immunotherapy Adverse Events Working Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol.<\/b> | 2024 Mar 26:S0923-7534(24)00083-8. doi: 10.1016\/j.annonc.2024.03.006. Online ahead of print. PMID: 38548063 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38546659\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Clonal CD8+ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Krzysiek R, Bitoun S, Belkhir R, Hacein-Bey-Abina S, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Haematologica.<\/b> | 2024 Mar 28. doi: 10.3324\/haematol.2023.284942. Online ahead of print. PMID: 38546659<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37540112\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Faganello D, Bertrand A, Meunier P, Avouac J, Toussirot E, Coury F, Seror R, Le M\u00e9l\u00e9do G, Germain V, Dellal A, Shima D, Hulin C, Prati C, Schaeverbeke T, Richez C, Truchetet ME, Kostine M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford).<\/b> | 2024 Mar 1;63(3):787-790. doi: 10.1093\/rheumatology\/kead187.PMID: 37540112<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38577249\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chevalier K, Hamroun S, Bitoun S, Henry J, Roux C, Briot K, Belkhir R, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Bone Rep.<\/b> | 2024 Mar 25;21:101755. doi: 10.1016\/j.bonr.2024.101755. eCollection 2024 Jun.PMID: 38577249 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38437852\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Identification of distinct subgroups of Sj\u00f6gren&rsquo;s disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Berg\u00e9 E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, S\u00e8ne D, Dieud\u00e9 P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2024 Mar 1:S2665-9913(23)00340-5. doi: 10.1016\/S2665-9913(23)00340-5. Online ahead of print. PMID: 38437852<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37796025\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Uzzan M, Nachury M, Nuzzo A, Amiot A, Caron B, Benezech A, Buisson A, Bouguen G, Le Berre C, Reenaers C, Le Cosquer G, Savoye G, Charkaoui M, Vidon M, Guillo L, Fumery M, Peyrin-Biroulet L, Kirchgesner J, Bouhnik Y; GETAID TOFA-PRO study group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Crohns Colitis.<\/b> | 2024 Mar 1;18(3):424-430. doi: 10.1093\/ecco-jcc\/jjad169.PMID: 37796025 Free article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38100159\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn&rsquo;s disease and ulcerative colitis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Dong C, Chan SSM, Touvier M, Julia C, Huybrechts I, Nicolas G, Oldenburg B, Heath AK, Tong TYN, Key TJ, Tj\u00f8nneland A, Kyr\u00f8 C, Kaaks R, Katzke VA, Bergman MM, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, S\u00e1nchez MJ, Guevara M, Grip O, Holmgren J, Cross A, Karling P, Hultdin J, Murphy N, Deschasaux-Tanguy M, Hercberg S, Galan P, Mahamat-Saleh Y, Amiot A, Gunter MJ, Boutron-Ruault MC, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2024 Feb;59(4):558-568. doi: 10.1111\/apt.17835. Epub 2023 Dec 15.PMID: 38100159 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37945315\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Obinutuzumab in patients with Sjogren&rsquo;s disease immunised against rituximab.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pezot M, Nocturne G, Belkhir R, Henry J, Pavy S, Seror R, Mariette X, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2024 Feb15;83(3):407-408. doi: 10.1136\/ard-2023-224999.PMID: 37945315 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38340608\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Identification of outcome domains in primary Sj\u00f6gren&rsquo;s disease: A scoping review by the OMERACT Sj\u00f6gren disease working group.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nguyen Y, Beydon M, Foulquier N, Gordon R, Bouillot C, Hammitt KM, Bowman SJ, Mariette X, McCoy SS, Cornec D, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Semin Arthritis Rheum.<\/b> | 2024 Jan 30;65:152385. doi: 10.1016\/j.semarthrit.2024.152385. Online ahead of print. PMID: 38340608<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38158294\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">[Managing cancer immunotherapy toxicities: Challenges and rechallenges for (young) internists].<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Guitton R, Lambotte O, Chiche L.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rev Med Interne.<\/b> | 2024 Jan;45(1):1-5. doi: 10.1016\/j.revmed.2023.12.003. Epub 2023 Dec 29. PMID: 38158294<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38199301\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Miranda S, Drouin J, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Gastroenterol Hepatol.<\/b> | 2024 Jan 8:S1542-3565(24)00010-7. doi: 10.1016\/j.cgh.2023.12.029. Online ahead of print.PMID: 38199301<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352187224000304\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">High rate of progression to symptomatic multiple myeloma in smoldering myeloma with isolated osteoporotic vertebral fracture.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chevalier K, Hamroun S, Bitoun S, Henry J, Roux C, Briot K, Belkhir R, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Bone Rep.<\/b> | 2024 Mar 25;21:101755. doi: 10.1016\/j.bonr.2024.101755. PMID: 38577249.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/academic.oup.com\/jbmrplus\/article\/8\/5\/ziae043\/7649071\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kachaner A, Seror R, Aubart FC, Henry J, Lazure T, Emile JF, Mariette X, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JBMR Plus.<\/b> | 2024 Apr 20;8(5):ziae043. doi: 10.1093\/jbmrpl\/ziae043. PMID: 38644976.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanrhe\/article\/PIIS2665-9913(24)00198-X\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Treatment modalities of marginal zone lymphoma and outcomes in Sj\u00f6gren\u2019s disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Rocca J, Beydon M, Le Guern V, Hachulla E, Couderc M, Jousse-Joulin S, Devauchelle-Pensec V, Gottenberg JE, Vittecoq O, Lavigne C, Schmidt J, Larroche C, Mariette X, Seror R, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Rheumatol.<\/b> | 2024 Oct;6(10):e703-e712. doi: 10.1016\/S2665-9913(24)00198-X. PMID: 39182508.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-4&quot;, &quot;openByDefault&quot;: false }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-4-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-4\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2023 <span class=\"nb-publications\">(37)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-4\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-4-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38057799\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bredel D, Tihic E, Mouraud S, Danlos FX, Susini S, Aglave M, Alfaro A, Mohamed-Djalim C, Rouanne M, Halse H, Bigorgne A, Tselikas L, Dalle S, Hartl DM, Baudin E, Guettier C, Vibert E, Rosmorduc O, Robert C, Ferlicot S, Parier B, Albiges L, de Montpreville VT, Besse B, Mercier O, Even C, Breuskin I, Classe M, Radulescu C, Lebret T, Pautier P, Gouy S, Scoazec JY, Zitvogel L, Marabelle A, Bonvalet M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Exp Clin Cancer Res.<\/b> | 2023 Dec 6;42(1):333. doi: 10.1186\/s13046-023-02897-6. PMID: 38057799 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37710354\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bresteau C, Bonnet P, Robert C, Mussini C, Saiag P, Buecher B, Lebbe C, Allez M, Benamouzig R, Hag\u00e8ge H, B\u00e9cheur H, Meyer A, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J GastroenterolHepatol.<\/b> | 2023 Dec;38(12):2104-2110. doi: 10.1111\/jgh.16349. Epub 2023 Sep 14.PMID: 37710354<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37308394\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">The PERFUSE study: The experience of patients receiving Adalimumab biosimilar SB5.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bouhnik Y, Carbonnel F, Fumery M, Flamant M, Buisson A, Camoin A, Addison J.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Dig Liver Dis.<\/b> | 2023 Dec;55(12):1658-1666. doi: 10.1016\/j.dld.2023.05.025. Epub 2023 Jun 10.PMID: 37308394 Free article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38110617\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Epidemiology of Sj\u00f6gren syndrome<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Maxime Beydon, Sara McCoy, Yann Nguyen, Takayuki Sumida, Xavier Mariette &amp; Rapha\u00e8le Seror<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nat Rev Rheumatol.<\/b> | 2023 Dec 18. doi: 10.1038\/s41584-023-01057-6. PMID: 38110617 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38073013\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Serum and tissue biomarkers associated with CRESS and STAR response to B-cell targeted therapy in TRACTISS trial of Sjogren&rsquo;s syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Pontarini E, Sciacca E, Chowdhury F, Grigoriadou S, Rivellese F, Murray-Brown WJ, Lucchesi D, Fossati-Jimack L, Nerviani A, Jaworska E, Ghirardi GM, Giacomassi C, Emery P, Ng WF, Sutcliffe N, Everett CC, Fernandez C, Tappuni AR, Seror R, Mariette X, Porcher R, Cavallaro G, Pulvirenti A, Verstappen G, de Wolff L, Arends S, Bootsma H, Lewis MJ, Pitzalis C, Bowman SJ, Bombardieri M; TRACTISS Study research group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Rheumatol.<\/b> | 2023 Dec 10. doi: 10.1002\/art.42772. Online ahead of print. PMID: 38073013<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37748398\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Alouani E, Laparra A, Perret A, Sakkal M, Messayke S, Danlos FX, Ouali K, Hollebecque A, Even C, Ammari S, Baldini C, Champiat S, Besse B, Robert C, Guettier C, Samuel D, Lambotte O, De Martin E, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2023 Nov;193:113313. doi: 10.1016\/j.ejca.2023.113313. Epub 2023 Aug 26. PMID: 37748398<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38030233\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ladouceur A, Barnetche T, Mouterde G, Tison A, Bitoun S, Prey S, Dutriaux C, Gerard E, Pham-Ledard A, Beylot-Barry M, Zysman M, Veillon R, Domblides C, Daste A, Gross-Goupil M, Sionneau B, Lefort F, Larroquette M, Richez C, Truchetet ME, Schaeverbeke T, Kostine M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2023 Nov 29;9(4):e003795. doi: 10.1136\/rmdopen-2023-003795. PMID:38030233<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37914214\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Sj\u00f6gren Syndrome: A Forgotten or an Overdiagnosed Entity?<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Rheumatol.<\/b> | 2023 Nov 1:jrheum.2023-0964. doi: 10.3899\/jrheum.2023-0964. Online ahead of print. PMID: 37914214<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.thelancet.com\/journals\/lanepe\/article\/PIIS2666-7762(23)00187-4\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Maxime Beydon, Sandrine Pinto, Yann De Rycke, Bruno Fautrel, Xavier Mariette, Rapha\u00e8le Seror, Florence Tubach et al.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>The Lancet Regional Health \u2013 Europe.<\/b> | Open Access Published: October 29, 2023DOI:https:\/\/doi.org\/10.1016\/j.lanepe.2023.100768<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34137641\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Delivering adapted physical activity by videoconference to patients with fatigue under immune checkpoint inhibitors: Lessons learned from the PACTIMe-FEAS feasibility study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Charles C, Bardet A, Ibrahimi N, Aromatario O, Cambon L, Imbert A, Pons M, Raynard B, Sauveplane D, Pouchepadass C, Baudinet C, Lambotte O, Marabelle A, Dauchy S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Telemed Telecare.<\/b> | 2023 Oct;29(9):716-724. doi: 10.1177\/1357633X211021743. Epub 2021 Jun 17.PMID: 34137641<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37115807\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Association Between Bruton&rsquo;s Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sj\u00f6gren&rsquo;s Syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A, Devauchelle-Pensec V, Seror R, Larroche C, Perdriger A, Sibilia J, Vallat L, Fornecker LM, Nocturne G, Mariette X, Gottenberg JE.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Rheumatol.<\/b> | 2023 Oct;75(10):1798-1811. doi: 10.1002\/art.42550. Epub 2023 Jul 28.PMID: 37115807<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37625239\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Secondary hypertrophic osteoarthropathy revealing a metastatic melanoma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Laillet J, Monnet P, Goldfarb L, Belkhir R, Robert C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2023 Oct;192:113247. doi: 10.1016\/j.ejca.2023.113247. Epub 2023 Aug 23. PMID:37625239No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37899092\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Comparison between primary Sj\u00f6gren&rsquo;s disease patients with high or low level of dryness.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kachaner A, Berg\u00e9 E, Desmoulins F, Le Pajolec C, Rousseau A, Labetoulle M, Nocturne G, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2023 Oct;9(4):e003291. doi: 10.1136\/rmdopen-2023-003291. PMID: 37899092 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37806566\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Ocular surface toxicities associated with modern anticancer therapies.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Boucher R, Haigh O, Barreau E, Champiat S, Lambotte O, Adam C, Labetoulle M, Rousseau A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>SurvOphthalmol.<\/b> | 2023 Oct 6:S0039-6257(23)00134-0. doi: 10.1016\/j.survophthal.2023.10.002. Online ahead of print. PMID: 37806566 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37657927\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Examining the biological pathways underlying clinical heterogeneity in Sjogren&rsquo;s syndrome: proteomic and network analysis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Berry JS, Tarn J, Casement J, Duret PM, Scott L, Wood K, Johnsen SJ, Nordmark G, Devauchelle-Pensec V, Seror R, Fisher B, Barone F, Bowman SJ, Bombardieri M, Lendrem D, Felten R, Gottenberg JE, Ng WF.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Annals of the Rheumatic Diseases<\/b> | 2023 Sep 1:ard-2023-224503. doi: 10.1136\/ard-2023-224503. PMID: 37657927<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36731590\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Narula N, Chang NH, Mohammad D, Wong ECL, Ananthakrishnan AN, Chan SSM, Carbonnel F, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Gastroenterol Hepatol.<\/b> | 2023 Sep;21(10):2483-2495.e1. doi: 10.1016\/j.cgh.2023.01.012. Epub 2023 Jan 31. PMID: 36731590 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36064096\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Rios P, Drouin J, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Gastroenterol Hepatol.<\/b> | 2023 Sep;21(10):2679-2681.e5. doi: 10.1016\/j.cgh.2022.08.028. Epub 2022 Sep 5. PMID: 36064096 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37730313\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Efficacy of daratumumab in refractory primary Sj\u00f6gren disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nocturne G, Marmontel O, di Filippo M, Chretien P, Krzysiek R, Lifermann F, Rahal N, Belkhir R, Moulin P, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2023 Sep;9(3):e003464. doi: 10.1136\/rmdopen-2023-003464. PMID: 37730313 Free PMC article. No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37477765\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">WallFlex\u00ae and Evolution\u00ae Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Martin A, Bellanger C, Carbonnel F, Boytchev I.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Dig Dis Sci.<\/b> | 2023 Sep;68(9):3688-3693. doi: 10.1007\/s10620-023-08036-7. Epub 2023 Jul 21.PMID: 37477765<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37527031\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Liposomal AntagomiR-155-5p restores anti-inflammatory macrophages and improves arthritis in pre-clinical models of Rheumatoid arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Paoletti A, Ly B, Cailleau C, Gao F, P\u00e9an de Ponfilly-Sotier M, Pascaud J, Rivi\u00e8re E, Yang L, Nwosu L, Elmesmari A, Reynaud F, Hita M, Paterson D, Reboud J, Fay F, Nocturne G, Tsapis N, McInnes IB, Kurowska-Stolarska M, Fattal E, Mariette X<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Rheumatol<\/b> | 2023 Aug 1. doi: 10.1002\/art.42665. PMID: 37527031<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37311941\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Post-transcriptional checkpoints in autoimmunity<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bechara R, Vagner S, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nature Reviews Rheumatology<\/b> | 2023 Aug;19(8):486-502. doi: 10.1038\/s41584-023-00980-y. Epub 2023 Jun 13. PMID: 37311941 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37436748\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bitoun S, H\u00e4ssler S, Ternant D, Szely N, Gleizes A, Richez C, Soubrier M, Avouac J, Brocq O, Sellam J, de Vries N, Huizinga TWJ, Jury EC, Manson JJ, Mauri C, Matucci A, Hacein Bey Abina S, Mulleman D, Pallardy M, Bro\u00ebt P, Mariette X; ABIRISK Consortium.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JAMA Netw Open<\/b> | 2023 Jul 3;6(7):e2323098. doi: 10.1001\/jamanetworkopen.2023.23098. PMID: 37436748<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36416134\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Duquesne J, Bouget V, Courn\u00e8de PH, Fautrel B, Guillemin F, de Jong PHP, Heutz JW, Verstappen M, van der Helm-van Mil AHM, Mariette X, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford).<\/b> | 2023 Jul 5;62(7):2402-2409. doi: 10.1093\/rheumatology\/keac645. PMID:36416134Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37289890\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Fidelle M, Rauber C, Alves Costa Silva C, Tian AL, Lahmar I, de La Varende AM, Zhao L, Thelemaque C, Lebhar I, Messaoudene M, Pizzato E, Birebent R, MbogningFonkou MD, Zoppi S, Reni A, Dalban C, Leduc M, Ferrere G, Durand S, Ly P, Silvin A, Mulder K, Dutertre CA, Ginhoux F, Yonekura S, Roberti MP, Tidjani-Alou M, Terrisse S, Chen J, Kepp O, Schippers A, Wagner N, Su\u00e1rez-Gos\u00e1lvez J, Kobold S, Fahrner JE, Richard C, Bosq J, Lordello L, Vitali G, Galleron N, Quinquis B, Le Chatelier E, Blanchard L, Girard JP, Jarry A, Gervois N, Godefroy E, Labarri\u00e8re N, Koschny R, Daill\u00e8re R, Besse B, Truntzer C, Ghiringhelli F, Coatnoan N, Mhanna V, Klatzmann D, Drubay D, Albiges L, Thomas AM, Segata N, Danlos FX, Marabelle A, Routy B, Derosa L, Kroemer G, Zitvogel L.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Science.<\/b> | 2023 Jun 9;380(6649):eabo2296. doi: 10.1126\/science.abo2296. Epub 2023 Jun 9. PMID: 37289890<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37476185\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Liu C, Shatila M, Mathew A, Machado AP, Thomas A, Zhang HC, Thomas AS, Faleck D, Funchain P, Philpott J, Grivas P, Obeid M, Carbonnel F, Wang Y.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Cancer.<\/b> | 2023 Jun 26;14(10):1913-1919. doi: 10.7150\/jca.84261. eCollection 2023.PMID: 37476185 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37258037\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Coustal C, Vanoverschelde J, Quantin X, Lesage C, Michot JM, Lappara A, Ederhy S, Assenat E, Faure M, Issa N, Lambotte O, Puyade M, Dereure O, Tosi D, Rullier P, Serre I, Larcher R, Klouche K, Chanques G, Vernhet-Kovacsik H, Faillie JL, Agullo A, Roubille F, Guilpain P, Maria ATJ.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Immunother Cancer.<\/b> | 2023 May;11(5):e004792. doi: 10.1136\/jitc-2022-004792. PMID: 37258037<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37053477\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Editorial: in search of environmental risk factors of Crohn&rsquo;s disease and ulcerative colitis with mendelian randomisation.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Amiot A, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2023 May;57(9):1032-1033. doi: 10.1111\/apt.17432.PMID: 37053477 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37219349\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">[An overview of immune checkpoint inhibitors toxicities].<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Rouvet G, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Med Sci (Paris).<\/b> | 2023 May;39(5):445-451. doi: 10.1051\/medsci\/2023066. Epub 2023 May 23. PMID: 37219349 French.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36578099\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Severe colitis in patients with melanoma treated with BRAF\/MEK inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Carbonnel F, Routier E, Lazure T, Mussini C, Bellanger C, Merklen C, Bejou B, Buisson A, Amiot A, Meyer A, Dong C, Robert C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2023 Apr;57(7):792-799. doi: 10.1111\/apt.17352. Epub 2022 Dec 28.PMID: 36578099<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36951162\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ascione S, Harel S, Besson FL, Belkhir R, Henry J, Royer B, Arnulf B, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Haematologica<\/b> | 2023 Mar 23. doi: 10.3324\/haematol.2022.282214. Online ahead of print. PMID:36951162<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36842758\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Cancer screening in chronic inflammatory rheumatic diseases.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Joanna Kedra, Rapha\u00e8le Seror<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine<\/b> | 2023 Feb 24:105557. doi: 10.1016\/j.jbspin.2023.105557. Online ahead of print.PMID: 36842758<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36599673\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Amphiphilic Phosphorus Dendrons Associated with Anti-inflammatory siRNA Reduce Symptoms in Murine Collagen-Induced Arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Yu Z, Tsapis N, Fay F, Chen L, Karpus A, Shi X, Cailleau C, Garc\u00eda P\u00e9rez S, Huang N, Vergnaud J, Mignani S, Majoral JP, Fattal E.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Biomacromolecules<\/b> | 2023 Feb 13;24(2):667-677. doi: 10.1021\/acs.biomac.2c01117. Epub 2023 Jan 4.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36151879\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, S\u00fchs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G; Immunotherapy for PML Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Neurol.<\/b> | 2023 Feb;93(2):257-270. doi: 10.1002\/ana.26512. Epub 2022 Oct 17.PMID: 36151879 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36403367\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Antoun S, Lanoy E, Ammari S, Farhane S, Martin L, Robert C, Planchard D, Routier E, Voisin AL, Messayke S, Champiat S, Michot JM, Laghouati S, Lambotte O, Marabelle A, Baracos V.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2023 Jan;178:49-59. doi: 10.1016\/j.ejca.2022.10.013. Epub 2022 Oct 27.PMID: 36403367<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36473326\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune-related generalised oedema &#8211; A new category of adverse events with immune checkpoint inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Velev M, Baroudjian B, Pruvost R, De Martin E, Laparra A, Babai S, Teysseire S, Danlos FX, Albiges L, Bernigaud C, Benderra MA, Prad\u00e8re P, Zaidan M, Decroisette C, Fallah F, Matergia G, Lavaud P, Jantzem H, Atzenhoffer M, Buyse V, Ammari S, Robert C, Champiat S, Messayke S, Marabelle A, Guettier C, Lebbe C, Lambotte O, Michot JM.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2023 Jan;179:28-47. doi: 10.1016\/j.ejca.2022.11.001. Epub 2022 Nov 12.PMID: 36473326<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35985961\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Guillo L, Flachaire B, Avouac J, Dong C, Nachury M, Bouguen G, Buisson A, Caillo L, Fumery M, Gilletta C, H\u00e9buterne X, Lafforgue P, Laharie D, Mah\u00e9 E, Marotte H, Nancey S, Ottaviani S, Salmon JH, Savoye G, Serrero M, Uzzan M, Viguier M, Richez C, Peyrin-Biroulet L, Seksik P, Pham T; COMBIO Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Dig Liver Dis.<\/b> | 2023 Jan;55(1):61-68. doi: 10.1016\/j.dld.2022.07.012. Epub 2022 Aug 16. PMID: 35985961<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36480723\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Editorial: ustekinumab during pregnancy &#8211; reassuring but still not enough.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Amiot A, Meyer A, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2023 Jan;57(1):158-159. doi: 10.1111\/apt.17260.PMID: 36480723 No abstract available.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-5&quot;, &quot;openByDefault&quot;: false }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-5-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-5\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2022 <span class=\"nb-publications\">(46)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-5\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-5-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36243353\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Food Processing and Risk of Crohn&rsquo;s Disease and Ulcerative Colitis: A European Prospective Cohort Study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, Rauber F, Levy RB, Millett C, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tj\u00f8nneland A, Kyr\u00f8 C, Kaaks R, Katzke VA, Bergman MM, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, S\u00e1nchez MJ, Grip O, Lindgren S, Luben R, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin GastroenterolHepatol.<\/b> | 2023Jun;21(6):1607-1616.e6. doi: 10.1016\/j.cgh.2022.09.031. Epub 2022 Oct 12. PMID: 36243353<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.nature.com\/articles\/s41591-022-02096-4\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Using genetics to predict toxicity of cancer immunotherapy<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Caroline Robert, St\u00e9phan Vagner &amp; Xavier Mariette<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nature Medicine<\/b> | volume 28, pages2471\u20132472 (2022)<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/academic.oup.com\/rheumatology\/advance-article-abstract\/doi\/10.1093\/rheumatology\/keac710\/6965626?redirectedFrom=fulltext&amp;login=false\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Lo\u00efc Meudec, Pauline Richeb\u00e9, Juliette Pascaud, Xavier Mariette, Gaetane Nocturne<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology<\/b> | keac710, https:\/\/doi.org\/10.1093\/rheumatology\/keac710<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35385104\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Hern\u00e1ndez-Molina G, Kostov B, Brito-Zer\u00f3n P, Vissink A, Mandl T, Hinrichs AC, Quartuccio L, Baldini C, Seror R, Sz\u00e1nt\u00f3 A, Isenberg D, Gerli R, Nordmark G, Rasmussen A, Solans-Laque R, Hofauer B, S\u00e8ne D, Pasoto SG, Rischmueller M, Praprotnik S, Gheita TA, Danda D, Arma\u011fan B, Suzuki Y, Valim V, Devauchelle-Pensec V, Retamozo S, Kvarnstrom M, Sebastian A, Atzeni F, Giacomelli R, Carsons SE, Kwok SK, Nakamura H, Fernandes Mo\u00e7a Trevisani V, Flores-Ch\u00e1vez A, Mariette X, Ramos-Casals M; Sj\u00f6gren Big Data Consortium.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford).<\/b> | 2022 Dec 23;62(1):243-255. doi: 10.1093\/rheumatology\/keac205.PMID: 35385104<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36539500\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immunotherapy advances in cancers with mismatch repair or proofreading deficiencies.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Alouani E, Rousseau B, Andre T, Marabelle A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nat Cancer.<\/b> | 2022 Dec;3(12):1414-1417. doi: 10.1038\/s43018-022-00497-5. PMID: 36539500No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36591609\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Lifestyle factors for the prevention of inflammatory bowel disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Lopes EW, Chan SSM, Song M, Ludvigsson JF, H\u00e5kansson N, Lochhead P, Clark A, Burke KE, Ananthakrishnan AN, Cross AJ, Palli D, Bergmann MM, Richter JM, Chan AT, Ol\u00e9n O, Wolk A, Khalili H; EPIC-IBD investigators.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Gut.<\/b> | 2022 Dec 6:gutjnl-2022-328174. doi: 10.1136\/gutjnl-2022-328174. Online ahead of print.PMID: 36591609<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36270461\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Haanen J, Obeid M, Spain L, Carbonnel F, Wang Y, Robert C, Lyon AR, Wick W, Kostine M, Peters S, Jordan K, Larkin J; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol.<\/b> | 2022 Dec;33(12):1217-1238. doi: 10.1016\/j.annonc.2022.10.001. Epub 2022 Oct 18.PMID: 36270461 Free article. No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36209941\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Japiassu KB, Fay F, Marengo A, Louaguenouni Y, Cailleau C, Denis S, Chapron D, Tsapis N, Nascimento TL, Lima EM, Fattal E.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Control Release<\/b> | 2022 Dec;352:15-24. doi: 10.1016\/j.jconrel.2022.10.006. Epub 2022 Oct 14. PMID: 36209941<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35819361\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Fumery M, Peyrin-Biroulet L, Filippi J, Altwegg R, Bouhnik Y, Serrero M, Laharie D, Roblin X, Nachury M, Abitbol V, Cadiot G, Nancey S, Allez M, Gilletta C, Vuitton L, Savoye G, Nahon S, Bourrier A, Buisson A, Bouguen G, Bourreille A, Viennot S, Carbonnel F, Amiot A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Scand J Gastroenterol.<\/b> | 2022 Dec;57(12):1454-1462. doi: 10.1080\/00365521.2022.2095668. Epub 2022 Jul 12. PMID: 35819361<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35998515\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kfoury M, Najean M, Lappara A, Voisin AL, Champiat S, Michot JM, Laghouati S, Robert C, Besse B, Soria JC, Lambotte O, Massard C, Marabelle A, Texier M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Cancer Treat Rev.<\/b> | 2022 Nov;110:102452. doi: 10.1016\/j.ctrv.2022.102452. Epub 2022 Aug 10.PMID: 35998515 Free article. Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36319066\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Gottenberg JE, Chaudier A, Allenbach Y, Mekinian A, Amoura Z, Cacoub P, Cornec D, Hachulla E, Quartier P, Melki I, Richez C, Seror R, Terrier B, Devauchelle-Pensec V, Henry J, Gatfosse M, Bouillet L, Gaigneux E, Andre V, Baulier G, Saunier A, Desmurs M, Poulet A, Ete M, Bienvenu B, Truchetet ME, Michaud M, Larroche C, Dellal A, Leurs A, Ottaviani S, Nielly H, Vial G, Jaussaud R, Rouvi\u00e8re B, Jeandel PY, Guffroy A, Korganow AS, Jouvray M, Meyer A, Chatelus E, Sordet C, Felten R, Sibilia J, Litim-Ahmed-Yahia S, Kleinmann JF, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2022 Nov;8(2):e002324. doi: 10.1136\/rmdopen-2022-002324.PMID: 36319066 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.nature.com\/articles\/s41467-022-34548-3\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Awatef Allouch, Laurent Voisin, Yanyan Zhang, Syed Qasim Raza, Yann Lecluse, Julien Calvo, Doroth\u00e9e Selimoglu-Buet, St\u00e9phane de Botton, Fawzia Louache, Fran\u00e7oise Pflumio, Eric Solary &amp; Jean-Luc Perfettini.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nature Communications<\/b> | doi: 10.1038\/s41467-022-34548-3 &#8211; Article number: 6739 (2022) &#8211; 08 November 2022<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36353627\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Aldea M, Belkhir R, Colomba E, Blanchard P, Danlos FX, Botticella A, Terlizzi M, Deutsch E, Le P\u00e9choux C, Planchard D, Michot JM, Besse B, Levy A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Front Immunol<\/b> | 2022 Oct 24;13:920130. doi: 10.3389\/fimmu.2022.920130. eCollection 2022. PMID: 36353627<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35850444\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Peyraud F, Gu\u00e9gan JP, Bodet D, Nafia I, Fontan L, Auzanneau C, Cousin S, Roubaud G, Cabart M, Chomy F, Le Loarer F, Chaput N, Danlos FX, Planchard D, Even C, Khettab M, Tselikas L, Besse B, Barlesi F, Soria JC, Marabelle A, Bessede A, Italiano A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol.<\/b> | 2022 Oct;33(10):1041-1051. doi: 10.1016\/j.annonc.2022.07.001. Epub 2022 Jul 16. PMID:35850444Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36162111\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Neumann A, Drouin J, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Intern Med.<\/b> | 2022 Oct;175(10):1374-1382. doi: 10.7326\/M22-0819. Epub 2022 Sep 27.PMID: 36162111 Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36270747\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">De La Fuente F, Belkhir R, Henry J, Nguyen CD, Pham T, Germain V, Gavand PE, Labadie C, Briere C, Lauret A, Cardon T, Mouterde G, Bonnet I, Rouxel L, Truchetet ME, Schaeverbeke T, Richez C, Kostine M; Club Rhumatismes and Inflammation (CRI).<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open<\/b> | 2022 Oct;8(2):e002612. doi: 10.1136\/rmdopen-2022-002612. PMID: 36270747<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35490943\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kedra J, Seror R, Dieud\u00e9 P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Fautrel B, Philippe P, Piperno M, Combe B, Lambotte O, Richez C, Sellam J, Sen\u00e9 T, Denis G, Lequerre T, Lazure T, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine<\/b> | 2022 Oct;89(5):105390. doi: 10.1016\/j.jbspin.2022.105390. Epub 2022 Apr 28. PMID: 35490943<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35843306\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Immune-related adverse events of cancer immunotherapies targeting kinases.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Ramos-Casals M, Flores-Ch\u00e1vez A, Brito-Zer\u00f3n P, Lambotte O, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Pharmacol Ther<\/b> | 2022 Sep;237:108250. doi: 10.1016\/j.pharmthera.2022.108250. Epub 2022 Jul 14. PMID: 35843306<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35973142\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Efficacy and Safety of Infliximab Retreatment in Crohn&rsquo;s Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Boschetti G, Nachury M, Laharie D, Roblin X, Gilletta C, Aubourg A, Bourreille A, Zallot C, Hebuterne X, Buisson A, Grimaud JC, Bouhnik Y, Allez M, Altwegg R, Viennot S, Vuitton L, Carbonnel F, Paul S, Desseaux K, Lambert J, Peyrin-Biroulet L.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Am J Gastroenterol.<\/b> | 2022 Sep 1;117(9):1482-1490. doi: 10.14309\/ajg.0000000000001842. Epub 2022 Jun 2. PMID: 35973142<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35999028\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bouget V, Duquesne J, Hassler S, Courn\u00e8de PH, Fautrel B, Guillemin F, Pallardy M, Bro\u00ebt P, Mariette X, Bitoun S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open<\/b> | 2022 Aug;8(2):e002442. doi: 10.1136\/rmdopen-2022-002442. PMID: 35999028<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34636895\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Reenaers C, de Roover A, Kohnen L, Nachury M, Simon M, Pourcher G, Trang-Poisson C, Rajca S, Msika S, Viennot S, Alttwegg R, Serrero M, Seksik P, Peyrin-Biroulet L, Picon L, BourbaoTournois C, Gontier R, Gilletta C, Stefanescu C, Laharie D, Roblin X, Nahon S, Bouguen G, Carbonnel F, Attar A, Louis E, Coffin B.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Inflamm Bowel Dis.<\/b> | 2022 Aug 1;28(8):1198-1206. doi: 10.1093\/ibd\/izab249.PMID: 34636895<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35588692\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high\/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Maio M, Amonkar MM, Norquist JM, Ascierto PA, Manzyuk L, Motola-Kuba D, Penel N, Cassier PA, Bariani GM, De Jesus Acosta A, Doi T, Longo F, Miller WH Jr, Oh DY, Gottfried M, Wang R, Norwood K, Marabelle A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2022 Jul;169:188-197. doi: 10.1016\/j.ejca.2022.03.040. Epub 2022 May 16. PMID:35588692<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35738803\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Seror R, Lafourcade A, De Rycke Y, Pinto S, Castaneda J, Fautrel B, Mariette X, Tubach F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open<\/b> | 2022 Jun;8(2):e002139. doi: 10.1136\/rmdopen-2021-002139. PMID: 35738803<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34298191\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Taine M, Drouin J, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Gastroenterol Hepatol.<\/b> | 2022 Jun;20(6):1269-1281.e9. doi: 10.1016\/j.cgh.2021.07.028. Epub 2021 Jul 21. PMID: 34298191<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35589332\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bitoun S, Avouac J, Henry J, Ghossan R, Al Tabaa O, Belkhir R, Nocturne G, Mariaggi AA, Rozenberg F, Vauloup-Fellous C, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open<\/b> | 2022 May;8(1):e002308. doi: 10.1136\/rmdopen-2022-002308. PMID: 35589332<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34962357\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bitoun S, Henry J, Desjardins D, Vauloup-Fellous C, Dib N, Belkhir R, Mouna L, Joly C, Bitu M, Ly B, Pascaud J, Seror R, Roque Afonso AM, Le Grand R, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Arthritis Rheumatol<\/b> | 2022 Jun;74(6):927-933. doi: 10.1002\/art.42058. Epub 2022 Mar 29. PMID: 34962357<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34940802\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Features of non-Hodgkin&rsquo;s lymphoma diagnosed in minor salivary gland biopsies from primary Sj\u00f6gren&rsquo;s syndrome patients.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, R\u00e9gent A, Mouthon L, Terrier B, Seror R, Le Guern V.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rheumatology (Oxford)<\/b> | 2022 Aug 30;61(9):3818-3823. doi: 10.1093\/rheumatology\/keab949. PMID: 34940802<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35726496\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Gonz\u00e1lez-S\u00e1nchez E, Mu\u00f1oz-Callejas A, G\u00f3mez-Rom\u00e1n J, San Antonio E, Marengo A, Tsapis N, Bohne-Japiassu K, Gonz\u00e1lez-Tajuelo R, Pereda S, Garc\u00eda-P\u00e9rez J, Cavagna L, Gonz\u00e1lez-Gay M\u00c1, Vicente-Rabaneda EF, Meloni F, Fattal E, Casta\u00f1eda S, Urzainqui A<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Br J Pharmacol<\/b> | 2022 Sep;179(18):4534-4548. doi: 10.1111\/bph.15898. Epub 2022 Jul 13. PMID:35726496<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34993924\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Sim\u00f3n-V\u00e1zquez R, Tsapis N, Lorscheider M, Rodr\u00edguez A, Calleja P, Mousnier L, de Miguel Villegas E, Gonz\u00e1lez-Fern\u00e1ndez \u00c1, Fattal E.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Drug DelivTransl Res<\/b> | 2022 May;12(5):1270-1284. doi: 10.1007\/s13346-021-01112-3. Epub 2022 Jan 6. PMID:34993924Free PMC article<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/api.repository.cam.ac.uk\/server\/api\/core\/bitstreams\/f94b23c7-c9c6-4ee9-a063-7ca91e326a46\/content\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Obesity is Associated With Increased Risk of Crohn&rsquo;s disease, but not Ulcerative Colitis: A Pooled Analysis of Five Prospective Cohort Studies.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chan SSM, Chen Y, Casey K, Olen O, Ludvigsson JF, Carbonnel F, Oldenburg B, Gunter MJ, Tj\u00f8nneland A, Grip O; DEFINe-IBD Investigators; Lochhead P, Chan AT, Wolk A, Khalili H.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Gastroenterol Hepatol.<\/b> | 2022 May;20(5):1048-1058. doi: 10.1016\/j.cgh.2021.06.049. Epub 2021 Jul<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36370683\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Prevalence and outcome of steroid-resistant\/refractory pneumonitis induced by immune checkpoint inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Camard M, Besse B, Cariou PL, Massayke S, Laparra A, Noel N, Michot JM, Ammari S, Pavec JL, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Respir Med Res.<\/b> | 2022 Nov;82:100969. doi: 10.1016\/j.resmer.2022.100969. Epub 2022 Nov 9.PMID: 36370683<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36078923\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Ocular Inflammation Induced by Immune Checkpoint Inhibitors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chaudot F, S\u00e8ve P, Rousseau A, Maria ATJ, Fournie P, Lozach P, Keraen J, Servant M, Muller R, Gramont B, Touhami S, Mahmoud H, Quintart PA, Dalle S, Lambotte O, Kodjikian L, Jamilloux Y.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Clin Med.<\/b> | 2022 Aug 25;11(17):4993. doi: 10.3390\/jcm11174993.PMID: 36078923 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35396592\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Study\u00f8.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tj\u00f8nneland A, Kyr\u00f8 C, Bueno de Mesquita B, Kaaks R, Katzke VA, Bergman MM, Boeing H, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, S\u00e1nchez MJ, Grip O, Lindgren S, Luben R, Huybrechts I, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Crohns Colitis.<\/b> | 2022 Aug 30;16(8):1187-1196. doi: 10.1093\/ecco-jcc\/jjac054.PMID: 35396592<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35879133\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">[Toxicity of cancer immunotherapies: Traps to not miss, the role of the internist].<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Rev Med Interne.<\/b> | 2022 Aug;43(8):459-461. doi: 10.1016\/j.revmed.2022.07.002. Epub 2022 Jul 22.PMID: 35879133 French. No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35740604\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Melin A, Routier \u00c9, Roy S, Pradere P, Le Pavec J, Pierre T, Chanson N, Scoazec JY, Lambotte O, Robert C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>2022 Jun 14;14(12):2937. doi: 10.3390\/cancers14122937.PMID: 35740604 Free PMC article.<\/b> | Cancers (Basel).<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32188691\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Martin de Fremont G, Belkhir R, Henry J, Voisin AL, Lambotte O, Besson FL, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2022 Mar;81(3):e52. doi: 10.1136\/annrheumdis-2020-217225. Epub 2020 Mar 18.PMID: 32188691 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798038\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Danese S, Colombel JF, Lukas M, Gisbert JP, D&#039;Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Gastroenterol Hepatol.<\/b> | 2022 Feb;7(2):118-127. doi: 10.1016\/S2468-1253(21)00294-6. Epub 2021 Nov 17.PMID: 34798038 Free article. Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798039\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Lancet Gastroenterol Hepatol.<\/b> | 2022 Feb;7(2):128-140. doi: 10.1016\/S2468-1253(21)00298-3. Epub 2021 Nov 17.PMID: 34798039 Free article. Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33847351\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn&rsquo;s Disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Alric H, Amiot A, Kirchgesner J, Tr\u00e9ton X, Allez M, Bouhnik Y, Beaugerie L, Carbonnel F, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Inflamm Bowel Dis.<\/b> | 2022 Feb 1;28(2):218-225. doi: 10.1093\/ibd\/izab060.PMID: 33847351<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34854100\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Systematic review with meta-analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn&rsquo;s disease refractory to anti-tumour necrosis factor.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Parrot L, Dong C, Carbonnel F, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2022 Feb;55(4):380-388. doi: 10.1111\/apt.16714. Epub 2021 Dec 1. PMID: 34854100<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37022357\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Flores-Ch\u00e1vez A, Brito-Zer\u00f3n P, Retamozo S, Bitoun S, Fisher BA, Liew D, Suijkerbuijk K, Chatzidionysiou K, Su\u00e1rez-Almazor M, Lambotte O, Mariette X, Ramos-Casals M.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Crit Rev Immunol.<\/b> | 2022;42(4):21-36. doi: 10.1615\/CritRevImmunol.2023047272.PMID: 37022357 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32066555\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO&rsquo;s adverse drug reactions database.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nguy\u1ec5n T, Maria ATJ, Ladhari C, Palassin P, Quantin X, Lesage C, Ta\u00efeb G, Ayrignac X, Rullier P, Hillaire-Buys D, Lambotte O, Guilpain P, Faillie JL.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis.<\/b> | 2022 Feb;81(2):e32. doi: 10.1136\/annrheumdis-2020-217018. Epub 2020 Feb 17.PMID: 32066555 Free article. No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34810048\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Panhaleux M, Espitia O, Terrier B, Manson G, Maria A, Humbert S, Godbert B, Perrin J, Achille A, Arrondeau J, Kostine M, Fallet V, Pugnet G, Chaigne B, Champiat S, Laparra A, Danlos FX, Launay D, Penel N, Lambotte O, Michot JM, Forestier A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Eur J Cancer.<\/b> | 2022 Jan;160:134-139. doi: 10.1016\/j.ejca.2021.10.018. Epub 2021 Nov 19.PMID: 34810048 Clinical Trial.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34970769\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Editorial: subcutaneous CT-P13 in Crohn&rsquo;s disease and ulcerative colitis-small change, big consequences.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Carbonnel F, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2022 Jan;55(2):251-252. doi: 10.1111\/apt.16709. PMID: 34970769 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35091460\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Cachen L, Nocturne G, Collins M, Meyer A, Gleizes A, Hacein-Bey-Abina S, Carbonnel F, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2022 Jan;8(1):e001697. doi: 10.1136\/rmdopen-2021-001697.PMID: 35091460 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33579790\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Oncogenetic landscape of lymphomagenesis in coeliac disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Cording S, Lhermitte L, Malamut G, Berrabah S, Trinquand A, Guegan N, Villarese P, Kaltenbach S, Meresse B, Khater S, Dussiot M, Bras M, Cheminant M, Tesson B, Bole-Feysot C, Bruneau J, Molina TJ, Sibon D, Macintyre E, Hermine O, Cellier C, Asnafi V, Cerf-Bensussan N; CELAC network.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Gut.<\/b> | 2022 Mar;71(3):497-508. doi: 10.1136\/gutjnl-2020-322935. Epub 2021 Feb 12.PMID: 33579790 Free PMC article.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-6&quot;, &quot;openByDefault&quot;: false }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-6-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-6\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Publications of 2021 <span class=\"nb-publications\">(20)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-6\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-6-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34788730\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Recommendations for risk management and better living with epilepsy. Phenomenological study of the experience of patients, relatives, and bereaved families.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">OudeEngberink A, Faucani\u00e9 M, Boulais M, N\u00e8gre-Pages L, Bourrel G, Jaussent A, Crespel A, Carbonnel F, Picot MC.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Epilepsy Behav.<\/b> | 2021 Dec;125:108412. doi: 10.1016\/j.yebeh.2021.108412. Epub 2021 Nov 14.PMID: 34788730<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33962799\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">[Hypophosphatemia following the administration of intravenous iron formulations: A case report and literature review].<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Lecoq AL, Dong C, Carbonnel F, Becquemont L.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Therapie.<\/b> | 2021 Nov-Dec;76(6):705-714. doi: 10.1016\/j.therap.2021.04.008. Epub 2021 Apr 21.PMID: 33962799 Review. French.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34426413\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">D&#039;Arcy ME, Beachler DC, Pfeiffer RM, Curtis JR, Mariette X, Seror R, Mahale P, Rivera DR, Yanik EL, Engels EA.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Cancer Epidemiol Biomarkers Prev.<\/b> | 2021 Nov;30(11):2059-2067. doi: 10.1158\/1055-9965.EPI-21-0125. Epub 2021 Aug 23.PMID: 34426413 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33662776\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Breton C, Meyer A, Malka D, Matias M, De Baere T, Hammel P, Sa Cunha A, Lucchese A, Fuks D, Coriat R, Gallois C, Touchefeu Y, Maillet M, Trouilloud I, Rompteaux P, Carbonnel F, Soularue E.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Res Hepatol Gastroenterol.<\/b> | 2021 Nov;45(6):101607. doi: 10.1016\/j.clinre.2020.101607. Epub 2021 Mar 2. PMID: 33662776<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34645504\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bitoun S, Henry J, Vauloup-Fellous C, Dib N, Belkhir R, Mouna L, Joly C, Desjardins D, Bitu M, Le Grand R, Seror R, Roque Afonso AM, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Hematol Oncol.<\/b> | 2021 Oct 13;14(1):166. doi: 10.1186\/s13045-021-01183-2. PMID: 34645504<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34470830\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Lymphoma complicating rheumatoid arthritis: results from a French case-control study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kedra J, Seror R, Dieud\u00e9 P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Goupille P, Sordet C, Fautrel B, Philippe P, Piperno M, Combe B, Lambotte O, Richez C, Sellam J, Sen\u00e9 T, Denis G, Lequerre T, Lazure T, Mariette X, Nocturne G.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>RMD Open.<\/b> | 2021 Sep;7(3):e001698. doi: 10.1136\/rmdopen-2021-001698. PMID: 34470830<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34132150\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Monitoring established Crohn&rsquo;s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Carretero C, Carbonnel F, Ferrante M, Knudsen T, Van Lent N, Lobo AJ, Negreanu L, Vojvodic A, Oliva S.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Curr Med Res Opin.<\/b> | 2021 Sep;37(9):1547-1554. doi: 10.1080\/03007995.2021.1940910. Epub 2021 Jun 30. PMID: 34132150<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33931341\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Chronic pouchitis and Crohn&rsquo;s disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Bresteau C, Amiot A, Kirchgesner J, de&#039;Angelis N, Lefevre JH, Bouhnik Y, Panis Y, Beaugerie L, Allez M, Brouquet A, Carbonnel F, Meyer A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Dig Liver Dis.<\/b> | 2021 Sep;53(9):1128-1135. doi: 10.1016\/j.dld.2021.03.027. Epub 2021 Apr 27.PMID: 33931341<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33864242\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nocturne G, Ly B, Paoletti A, Pascaud J, Seror R, Nicco C, Mackay F, Vincent FB, Lazure T, Ferlicot S, Stimmer L, Pascal Q, Roulland S, Krzysiek R, Hacein-Bey S, Batteux F, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Clin Exp Immunol.<\/b> | 2021 Aug;205(2):169-181. doi: 10.1111\/cei.13602. Epub 2021 May 30. PMID: 33864242<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34425887\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn&rsquo;s disease.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chevalier G, Laveissi\u00e8re A, Desachy G, Barnich N, Sivignon A, Maresca M, Nicoletti C, Di Pasquale E, Martinez-Medina M, Simpson KW, Yajnik V, Sokol H; MOBIDIC Study Investigators; Plassais J, Strozzi F, Cervino A, Morra R, Bonny C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Microbiome.<\/b> | 2021 Aug 23;9(1):176. doi: 10.1186\/s40168-021-01135-5.PMID: 34425887 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34151448\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Uzzan M, Bresteau C, Laharie D, Stefanescu C, Bellanger C, Carbonnel F, Serrero M, Viennot S, Nachury M, Amiot A, Altwegg R, Picon L, Nahon S, Vuitton L, Ah Soune P, Kirchgesner J, Peyrin-Biroulet L, Bouhnik Y; GETAID-TALC Study Group.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2021 Aug;54(3):312-319. doi: 10.1111\/apt.16463. Epub 2021 Jun 20.PMID: 34151448<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34162011\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and\/or anti-TNF: a French nationwide study 2010-2018.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Drouin J, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2021 Aug;54(3):302-311. doi: 10.1111\/apt.16448. Epub 2021 Jun 23.PMID: 34162011<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33771759\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Inflammation-targeted therapies and cancer.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Kedra J, Nocturne G, Mariette X, Seror R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine.<\/b> | 2021 Jul;88(4):105176. doi: 10.1016\/j.jbspin.2021.105176. Epub 2021 Mar 23. PMID: 33771759<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34188206\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Current and future therapies for primary Sj\u00f6gren syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Seror R, Nocturne G, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nat Rev Rheumatol.<\/b> | 2021 Aug;17(8):475-486. doi: 10.1038\/s41584-021-00634-x. Epub 2021 Jun 29.PMID: 34188206 Review.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34183155\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieud\u00e9 P, Goupille P, Kluger N, Lazaro E, Le Goff B, de L\u00e9dinghen V, Lequerr\u00e9 T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine.<\/b> | 2021 Jun;88(4 Suppl 1):105221. doi: 10.1016\/j.jbspin.2021.105221.PMID: 34183155 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34110040\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Meyer A, Semenzato L, Zureik M, Weill A, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Aliment PharmacolTher.<\/b> | 2021 Jul;54(2):160-166. doi: 10.1111\/apt.16410. Epub 2021 Jun 10. PMID: 34110040<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34074455\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, L\u00e9dinghen V, Lequerr\u00e9 T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Richez C, Pham T.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine.<\/b> | 2021 May;88(3 Suppl 1):105210. doi: 10.1016\/j.jbspin.2021.105210.PMID: 34074455 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33992225\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">PRACTICAL MANAGEMENT of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Sellam J, Morel J, Tournadre A, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieud\u00e9 P, Goupille P, Jullien D, Kluger N, Lazaro E, Le Goff B, de L\u00e9dinghen V, Lequerr\u00e9 T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Joint Bone Spine.<\/b> | 2021 May;88(2 Suppl 1):105174. doi: 10.1016\/j.jbspin.2021.105174.PMID: 33992225 No abstract available.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34121974\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Collins M, Michot JM, Bellanger C, Mussini C, Benhadji K, Massard C, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>EXCLI J.<\/b> | 2021 Apr26;20:819-827. doi: 10.17179\/excli2021-3572. eCollection 2021.PMID: 34121974 Free PMC article.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32969469\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Impact of an Education Programme on IBD Patients&rsquo; Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Moreau J, Hammoudi N, Marthey L, Trang-Poisson C, Nachury M, Altwegg R, Grimaud JC, Orempuller S, H\u00e9buterne X, Aubourg A, Baudry C, Seksik P, Roblin X, Nahon S, Savoye G, Mesnard B, Stefanescu C, Simon M, Coffin B, Fumery M, Carbonnel F, Peyrin-Biroulet L, Desseaux K, Allez M; GETAID.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>J Crohns Colitis.<\/b> | 2021 Mar 5;15(3):432-440. doi: 10.1093\/ecco-jcc\/jjaa195.PMID: 32969469 Clinical Trial.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-7&quot;, &quot;openByDefault&quot;: false }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-7-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-7\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Main publications from the project leaders pertaining to the FHU CARE <span class=\"nb-publications\">(5)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-7\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-7-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29514034\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Primary Sj\u00f6gren&rsquo;s Syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Mariette X, Criswell LA.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>N Engl J Med<\/b> | 2018 Mar 8;378(10):931-939.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29416129\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">B cells in the pathogenesis of primary Sj\u00f6gren syndrome.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Nocturne G, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Nat Rev Rheumatol<\/b> | 2018 Mar;14(3):133-145.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31169866\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Simonaggio A, Michot JM, Voisin AL, Le Pavec J, Collins M, Lallart A, Cengizalp G, Vozy A, Laparra A, Varga A, Hollebecque A, Champiat S, Marabelle A, Massard C, Lambotte O.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JAMA Oncol<\/b> | 2019 Jun 6. doi: 10.1001\/jamaoncol.2019.1022.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26541610\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, B\u00e9rard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Science<\/b> | 2015 Nov 27;350(6264):1079-84.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29097494\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondrag\u00f3n L, Jacquelot N, Qu B, Ferrere G, Cl\u00e9menson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G,* Zitvogel L.* (*Co-corresponding authors).<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Science<\/b> | 2018 Jan 5;359(6371):91-97.<\/p>\n\n<\/div><\/div><\/div><\/div>\n\n<div data-wp-context=\"{ &quot;autoclose&quot;: true, &quot;accordionItems&quot;: [] }\" data-wp-interactive=\"core\/accordion\" role=\"group\" class=\"wp-block-accordion is-layout-flow wp-container-core-accordion-is-layout-119bc444 wp-block-accordion-is-layout-flow\">\n    \n    <div data-wp-class--is-open=\"state.isOpen\" data-wp-context=\"{ &quot;id&quot;: &quot;accordion-item-8&quot;, &quot;openByDefault&quot;: false }\" data-wp-init=\"callbacks.initAccordionItems\" data-wp-on-window--hashchange=\"callbacks.hashChange\" class=\"wp-block-accordion-item is-layout-flow wp-block-accordion-item-is-layout-flow\">\n        \n        <h2 class=\"wp-block-accordion-heading\">\n            <button aria-controls=\"accordion-item-8-panel\" data-wp-bind--aria-expanded=\"state.isOpen\" data-wp-on--click=\"actions.toggle\" data-wp-on--keydown=\"actions.handleKeyDown\" id=\"accordion-item-8\" class=\"wp-block-accordion-heading__toggle\">\n                <span class=\"wp-block-accordion-heading__toggle-icon\" aria-hidden=\"true\">+<\/span>\n                <span class=\"wp-block-accordion-heading__toggle-title\">Previous Publications related to the research project (not necessarily by members of the FHU CARE) <span class=\"nb-publications\">(5)<\/span><\/span>\n            <\/button>\n        <\/h2>\n        \n<div aria-labelledby=\"accordion-item-8\" data-wp-bind--inert=\"!state.isOpen\" id=\"accordion-item-8-panel\" role=\"region\" class=\"wp-block-accordion-panel\"><div class=\"publication is-layout-flow wp-block-accordion-panel-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28368458\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Chaput N, Lepage P,  Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol<\/b> | 2017 Jun 1;28(6):1368-1379<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29114832\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>JAMA<\/b> | 2017 Nov 7;318(17):1679-1686.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28600350\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B, Leary A, Voisin AL, Pontoizeau C, Coutte L, Pertuiset E, Mouterde G, Fain O, Lambotte O, Mariette X.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Rheum Dis<\/b> | 2017 Oct;76(10):1747-1750.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26715621\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Champiat S, Lambotte O, Barreau E, Belkhir R, Berdelou A, Carbonnel F, Cauquil C, Chanson P, Collins M, Durrbach A, Ederhy S, Feuillet S, Fran\u00e7ois H, Lazarovici J, Le Pavec J, De Martin E, Mateus C, Michot JM, Samuel D, Soria JC, Robert C, Eggermont A, Marabelle A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Ann Oncol<\/b> | 2016 Apr;27(4):559-74.<\/p>\n\n<\/div><div class=\"publication\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24310608\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Association of the autoimmune disease scleroderma with an immunologic response to cancer<\/a><\/h3>\n\n<p class=\"has-small-font-size\">Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I, Jiao Y, Papadopoulos N, Kinzler KW, Vogelstein B, Rosen A.<\/p>\n\n<p class=\"has-small-font-size src-infos\"><b>Science<\/b> | 2014 Jan 10;343(6167):152-7.<\/p>\n\n<\/div><\/div><\/div><\/div><\/div><script>\n    window.onload = function() {\n        console.log('Running !!!');\n        var countpub =  document.getElementsByClassName('publication').length;\n        console.log(countpub);\n        document.querySelector('h1').innerHTML = 'Scientific Publications '+'<span class=\"nb-publications\">(170 entries)<\/span>';\n    };\n<\/script>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":50,"comment_status":"closed","ping_status":"closed","template":"page-no-title","meta":{"footnotes":""},"class_list":["post-2299","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/pages\/2299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=2299"}],"version-history":[{"count":3,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/pages\/2299\/revisions"}],"predecessor-version":[{"id":4306,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/pages\/2299\/revisions\/4306"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=2299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}